Navigation Links
Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award
Date:12/15/2009

IRVINE, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that Masimo Chairman and CEO Joe Kiani has been awarded the 2009 Frost & Sullivan CEO of the Year Award in the North American Patient Monitoring market. According to Frost & Sullivan, the award is presented in recognition of Mr. Kiani's "unprecedented ability in understanding customer requirements, developing new technologies, delivering relevant products, and thereby exploiting new market opportunities. In leading Masimo, he has not only made technology innovation the core of the company's philosophy but also equally emphasized protection of that innovation through patent licensing and OEM contracts with established patient monitoring manufacturing companies such as GE Medical, Philips, Zoll, Atom, Draeger, and Medtronic. While accomplishing all of these things, Masimo and Mr. Kiani have also been recognized for their integrity in conducting business and truthfulness in advertising."

In its summary outlining the reasons they chose to honor Kiani with the CEO of the Year award, Frost & Sullivan referenced his significant contributions to the industry, starting with the development of Masimo SET pulse oximetry. With the assistance of his friend and fellow engineer Mohamed Diab, Frost & Sullivan noted, "Kiani embarked on achieving the impossible goal of developing a pulse oximetry technology that provides precise, reliable measurements during low peripheral profusion and patient motion. The outcome of this endeavor was the invention of a breakthrough technology in pulse oximetry, Masimo SET, which considerably reduced false alarms and increased the instrument's capability of detecting critical conditions."

"This revolut
'/>"/>

SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
2. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
3. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
4. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
5. Masimo to Report Third Quarter 2009 Financial Results on November 3, 2009
6. New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
7. New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood
8. CareFusion Signs Multi-Year Technology Licensing Agreement for Masimo Rainbow SET(R) Pulse CO-Oximetry(TM)
9. Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress
10. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
11. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... A new Manhattan Research study, ... finds that members of pharmacy and therapeutics ... and pharmacy benefits managers (PBMs) are shifting the ... of formulary decision makers report that they are ... decision making process today than a year ago. ...
(Date:7/14/2014)...  Clinicians at a leading cancer center in ... first in the country to commence advanced lung, ... Clinac® medical linear accelerator from Varian Medical Systems ... High Intensity Mode dose delivery capability, which is ... treatment times and deliver stereotactic body radiotherapy and ...
(Date:7/14/2014)... 14, 2014  Patients and patient advocates are rallying ... and other major pharmacy benefit managers (PBMs) begin unprecedented ... impact millions of patients who rely on compounded medicines ... pain from cancer, diabetes and other illnesses. Express Scripts ... on July 15. In a matter of ...
Breaking Medicine Technology:Digital Resources Play Critical Role in Formulary Decision Making 2Digital Resources Play Critical Role in Formulary Decision Making 3Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator 2Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator 3Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 2Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 3Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 4
... SOUTHAMPTON, England, June 29 Vantia ... drugs,targeting large, underserved medical markets, announces positive results ... development compound VA106483 for,nocturia. The trial showed that ... sustained anti-diuretic effect in patients, as determined by,increased ...
... England and TOKYO, June 29 , ... Sosei Group Corporation ("Sosei"; TSE Mothers ... commencement of a Phase III,clinical study by Novartis, with NVA237, ... obstructive pulmonary disease,(COPD). NVA237 is a dry powder formulation for ...
Cached Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4
(Date:7/14/2014)... July 14, 2014 Felicity Philp was diagnosed ... 29 years old. Instead of letting her health issues decrease ... food she was eating and began to see a difference ... two friends and business partners, Julie Reardon and Kate Owen, ... help others with this lifestyle change as well. In their ...
(Date:7/14/2014)... Georgia State University is starting four new ... round of its Second Century Initiative, aiming to ... performance. , The Second Century Initiative (2CI) ... to the university, with the goal of building ... significance. , “With the fifth round of the ...
(Date:7/14/2014)... , Scientists funded by the National Institutes of Health ... esophagitis (EoE), an inflammatory disease characterized by high ... Their findings suggest that several genes are involved in ... and often is associated with food allergies. The findings ... the esophagus. The work was supported in part by ...
(Date:7/14/2014)... PA, July 14, 2014 The inability to ignore ... often experienced by individuals diagnosed with schizophrenia, reports a ... Psychiatry . , Our brains are usually good at ... learn and filtering out the "noise" or thoughts that ... related in part to a problem with this filtering ...
(Date:7/14/2014)... Hicksville and Hauppauge, NY (PRWEB) July 14, 2014 ... York (RGONY), with offices in Hicksville and Hauppauge, ... intravitreal implant) as a long-lasting treatment for diabetic ... by Allergan, recently obtained an additional FDA-approved indication ... previously approved by the FDA in 2009 for ...
Breaking Medicine News(10 mins):Health News:Women Changing Lives Through Food 2Health News:Georgia State Starts Four Innovative Research Groups Through Fifth Round of Its Second Century Initiative 2Health News:Georgia State Starts Four Innovative Research Groups Through Fifth Round of Its Second Century Initiative 3Health News:Scientists deepen genetic understanding of eosinophilic esophagitis 2Health News:'Noisy' memory in schizophrenia 2Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 2Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 3
... ... ... ... ...
... who have both diabetes and major depression are more than ... diabetes only, according to a study published in the recent ... the progressive decline of thinking and reasoning abilities. These can ... the past, personality changes, and not recognizing familiar people. ...
... researchers say , FRIDAY, March 5 (HealthDay News) -- Freezing ... mice, a new study has found. , Researchers tested two ... applying a cold probe to the tumor, but one method ... the other takes a few minutes. The mice that received ...
... ... ... ... ...
... , ... ... ... ...
... report released today by Rice University,s Jones Graduate School of ... since October 2009, current Toyota owners are not yet wavering ... The rigorous survey-based study of a national sample ... satisfaction with their vehicles, quality was equally high among Toyota ...
Cached Medicine News:Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 2Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 3Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 4Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 5Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 6Health News:Major depression more than doubles risk of dementia among adults with diabetes 2Health News:Major depression more than doubles risk of dementia among adults with diabetes 3Health News:Freezing Technique May Stop Breast Cancer 2Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 2Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 3Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 4Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 5Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 6Health News:Summit Seeks to Spark Call to Action on Facing World's Biggest Challenges 2Health News:Summit Seeks to Spark Call to Action on Facing World's Biggest Challenges 3Health News:Summit Seeks to Spark Call to Action on Facing World's Biggest Challenges 4Health News:Summit Seeks to Spark Call to Action on Facing World's Biggest Challenges 5Health News:Survey: Toyota owners maintain high overall satisfaction despite recalls 2
Disposable Feather Blades, 50 per pack...
Knife sharpening back for Standard Knife, C Profile...
... The Cryostage freezing stage is a refrigerated design ... holder, primarily for use with the 8000 sledge ... sledge microtomes. ,The refrigerated stage gives a large ... surface is ridged to provide good adhesion between ...
... necessary to cool a specimen below room temperature. ... most microtomes and will permit specimen cooling from ... The equipment consists of a cooling stage and ... suited for operation with a base sledge microtome, ...
Medicine Products: